U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C23H22N6O4S
Molecular Weight 478.524
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of OMIDENEPAG

SMILES

OC(=O)CNC1=NC(CN(CC2=CC=C(C=C2)N3C=CC=N3)S(=O)(=O)C4=CN=CC=C4)=CC=C1

InChI

InChIKey=YHGSTSNEOJUIRN-UHFFFAOYSA-N
InChI=1S/C23H22N6O4S/c30-23(31)15-25-22-6-1-4-19(27-22)17-28(34(32,33)21-5-2-11-24-14-21)16-18-7-9-20(10-8-18)29-13-3-12-26-29/h1-14H,15-17H2,(H,25,27)(H,30,31)

HIDE SMILES / InChI
Molecular Formula C23H22N6O4S
Molecular Weight 478.524
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

2022
358
Substance Class Chemical
Created
by admin
on Sat Dec 16 11:25:05 UTC 2023
Edited
by admin
on Sat Dec 16 11:25:05 UTC 2023
Record UNII
Z95F9F9LU4
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
OMIDENEPAG
INN   USAN  
INN   USAN  
Official Name English
GLYCINE, N-(6-((((4-(1H-PYRAZOL-1-YL)PHENYL)METHYL)(3-PYRIDINYLSULFONYL)AMINO)METHYL)-2-PYRIDINYL)-
Systematic Name English
((6-(((4-(PYRAZOL-1-YL)BENZYL)(PYRIDIN-3-YLSULFONYL)AMINO)METHYL)PYRIDIN-2-YL)AMINO)ACETIC ACID
Systematic Name English
UR-7276
Code English
((6-((N-((4-(1H-PYRAZOL-1-YL)PHENYL)METHYL)PYRIDINE-3-SULFONAMIDO)METHYL)PYRIDIN-2-YL)AMINO)ACETIC ACID
Systematic Name English
omidenepag [INN]
Common Name English
Omidenepag [WHO-DD]
Common Name English
OMIDENEPAG [USAN]
Common Name English
Classification Tree Code System Code
WHO-ATC S01EX06
Created by admin on Sat Dec 16 11:25:05 UTC 2023 , Edited by admin on Sat Dec 16 11:25:05 UTC 2023
Code System Code Type Description
PUBCHEM
44230575
Created by admin on Sat Dec 16 11:25:05 UTC 2023 , Edited by admin on Sat Dec 16 11:25:05 UTC 2023
PRIMARY
RXCUI
2612691
Created by admin on Sat Dec 16 11:25:05 UTC 2023 , Edited by admin on Sat Dec 16 11:25:05 UTC 2023
PRIMARY
CAS
1187451-41-7
Created by admin on Sat Dec 16 11:25:05 UTC 2023 , Edited by admin on Sat Dec 16 11:25:05 UTC 2023
PRIMARY
ChEMBL
CHEMBL3707245
Created by admin on Sat Dec 16 11:25:05 UTC 2023 , Edited by admin on Sat Dec 16 11:25:05 UTC 2023
PRIMARY
SMS_ID
100000174923
Created by admin on Sat Dec 16 11:25:06 UTC 2023 , Edited by admin on Sat Dec 16 11:25:06 UTC 2023
PRIMARY
NCI_THESAURUS
C170253
Created by admin on Sat Dec 16 11:25:05 UTC 2023 , Edited by admin on Sat Dec 16 11:25:05 UTC 2023
PRIMARY
FDA UNII
Z95F9F9LU4
Created by admin on Sat Dec 16 11:25:05 UTC 2023 , Edited by admin on Sat Dec 16 11:25:05 UTC 2023
PRIMARY
USAN
DE-15
Created by admin on Sat Dec 16 11:25:06 UTC 2023 , Edited by admin on Sat Dec 16 11:25:06 UTC 2023
PRIMARY
INN
10214
Created by admin on Sat Dec 16 11:25:05 UTC 2023 , Edited by admin on Sat Dec 16 11:25:05 UTC 2023
PRIMARY
DAILYMED
Z95F9F9LU4
Created by admin on Sat Dec 16 11:25:05 UTC 2023 , Edited by admin on Sat Dec 16 11:25:05 UTC 2023
PRIMARY
Related Record Type Details
PROSTAGLANDIN E2 RECEPTOR EP2 SUBTYPE
TARGET -> AGONIST
Related Record Type Details
Structure of OMIDENEPAG ISOPROPYL
PRODRUG -> METABOLITE ACTIVE
Related Record Type Details
Structure of OMIDENEPAG
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966